Literature DB >> 26309570

Upregulation of miR-195 enhances the radiosensitivity of breast cancer cells through the inhibition of BCL-2.

Jian Zhu1, Qing Ye2, Li Chang2, Wei Xiong2, Qingqing He1, Wenhui Li2.   

Abstract

AIMS: To investigate the effect of miR-195 overexpression on radiosensitivity and the relevant molecular mechanisms in breast cancer.
METHODS: miR-195 mimics were transfected to breast cancer cell line MCF-7 by gene transfection; miR-195 expression level in cells was determined by real-time quantitative PCR. Cellular viability was observed by colony formation assay after the cells were irradiated with X-ray. Apoptosis was detected by annexin V/propidium iodide (PI) staining. Protein expression was evaluated by Western blot assay.
RESULTS: After miR-195 mimics were transfected, miR-195 expression in breast cancer cells was significantly upregulated (P < 0.05). miR-195 overexpression significantly enhanced the response to radiation of MCF-7 cells with a decrease in colony survival at individual doses of X-ray (P < 0.05). After the cells were irradiated with 5 Gy, apoptotic rate was significantly increased in miR-195-overexpressed group with a rate of 18.13% ± 1.57%; moreover, BCL-2 protein expression was significantly downregulated (P < 0.05).
CONCLUSION: Exogenetic miR-195 expression could significantly enhance the radiosensitivity of human breast cancer cells; this finding may be attributed to BCL-2 downregulation to promote radiation-induced apoptosis.

Entities:  

Keywords:  Breast cancer; apoptosis; miR-195; radiosensitivity

Year:  2015        PMID: 26309570      PMCID: PMC4538095     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

Review 1.  The Bcl-2 family: structures, interactions and targets for drug discovery.

Authors:  Marc Kvansakul; Mark G Hinds
Journal:  Apoptosis       Date:  2015-02       Impact factor: 4.677

2.  Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma.

Authors:  Yi Li; Gang Meng; Qiao-nan Guo
Journal:  Exp Mol Pathol       Date:  2008-04-16       Impact factor: 3.362

Review 3.  Management of the regional lymph nodes following breast-conservation therapy for early-stage breast cancer: an evolving paradigm.

Authors:  Laura E G Warren; Rinaa S Punglia; Julia S Wong; Jennifer R Bellon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-18       Impact factor: 7.038

4.  MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.

Authors:  Xiang Fei; Manlong Qi; Bin Wu; Yongsheng Song; Yueping Wang; Tingting Li
Journal:  FEBS Lett       Date:  2012-01-16       Impact factor: 4.124

5.  Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.

Authors:  Fu-long Zhao; Yue-chao Dou; Xue-fei Wang; Da-cheng Han; Zhen-gang Lv; Shuang-lei Ge; Ya-kui Zhang
Journal:  Mol Biol Rep       Date:  2014-08-08       Impact factor: 2.316

6.  Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.

Authors:  Dan Li; Yulan Zhao; Changxing Liu; Xiaona Chen; Yanting Qi; Yue Jiang; Chao Zou; Xiaolong Zhang; Shunying Liu; Xuejing Wang; Dan Zhao; Qiang Sun; Zhenbing Zeng; Andreas Dress; Marie C Lin; Hsiang-Fu Kung; Hallgeir Rui; Ling-Zhi Liu; Feng Mao; Bing-Hua Jiang; Lihui Lai
Journal:  Clin Cancer Res       Date:  2011-02-24       Impact factor: 12.531

7.  MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency.

Authors:  Yu-Qiang Chen; Xiao-Xia Wang; Xing-Mei Yao; Dong-Liang Zhang; Xu-Feng Yang; Shou-Fu Tian; Nian-Song Wang
Journal:  Am J Nephrol       Date:  2011-11-25       Impact factor: 3.754

8.  MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1.

Authors:  Huaqing Zhu; Yixin Yang; Yanpeng Wang; Jianmin Li; Peter W Schiller; Tianqing Peng
Journal:  Cardiovasc Res       Date:  2011-05-27       Impact factor: 10.787

9.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

10.  MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.

Authors:  Joanne B Weidhaas; Imran Babar; Sunitha M Nallur; Phong Trang; Sarah Roush; Michelle Boehm; Erin Gillespie; Frank J Slack
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

View more
  10 in total

1.  miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer.

Authors:  Xiaojie Yu; Yiqiang Zhang; Xiuye Ma; Alexander Pertsemlidis
Journal:  Cancer Lett       Date:  2018-04-13       Impact factor: 8.679

Review 2.  Noncoding RNAs in breast cancer.

Authors:  Pang-Kuo Lo; Benjamin Wolfson; Xipeng Zhou; Nadire Duru; Ramkishore Gernapudi; Qun Zhou
Journal:  Brief Funct Genomics       Date:  2015-12-18       Impact factor: 4.241

Review 3.  Role of non-coding RNAs in response of breast cancer to radiation therapy.

Authors:  Nastaran Masoudi-Khoram; Parviz Abdolmaleki
Journal:  Mol Biol Rep       Date:  2022-02-25       Impact factor: 2.742

4.  miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.

Authors:  Tong Wang; Yipeng Ren; Ruixun Liu; Juntao Ma; Yueyi Shi; Lei Zhang; Rongfa Bu
Journal:  Biomed Res Int       Date:  2017-10-24       Impact factor: 3.411

5.  MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.

Authors:  Yali Yin; Shubin Hong; Shuang Yu; Yanrui Huang; Shuwei Chen; Yujie Liu; Quan Zhang; Yanbing Li; Haipeng Xiao
Journal:  Int J Endocrinol       Date:  2017-06-27       Impact factor: 3.257

6.  MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.

Authors:  Rongrong Song; Lin Cong; Guantai Ni; Min Chen; Honmei Sun; Yunxia Sun; Meiling Chen
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

7.  miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1.

Authors:  Li Zheng; Jiangtao Chen; Zhongyong Zhou; Zhikuan He
Journal:  Onco Targets Ther       Date:  2017-02-20       Impact factor: 4.147

8.  Khat promotes human breast cancer MDA-MB-231 cell apoptosis via mitochondria and MAPK-associated pathways.

Authors:  Yu Lu; Yanyan Li; Min Xiang; Jie Zhou; Juan Chen
Journal:  Oncol Lett       Date:  2017-08-02       Impact factor: 2.967

9.  MicroRNA-195 as a prognostic factor for cancer survival outcome in China: a meta-analysis.

Authors:  Ni Wang; Yang Cao; Xianxiu Ge; Junjie Nie; Yang Yu; Quanpeng Li; Fei Wang; Lin Miao
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989

10.  miR-195 Inhibits Proliferation and Enhances Apoptosis of OSCC Cells via Targeting TLR4.

Authors:  Jianguo Wang; Renyou Song; Chunmei Wang; Shuangsheng Zhang; Yanqi Zhang; Yanlong Zhu; Gang Zhao
Journal:  J Healthc Eng       Date:  2022-03-09       Impact factor: 2.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.